Coppell Advisory Solutions’s ProShares Ultra Health Care RXL Stock Holding History

Coppell Advisory Solutions’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,156	Closed	-$50.8K	–	1536
2024 Q4	$50.8K	Hold	1,156	–	–	0.01%	579
2024 Q3	$63.9K	Buy	1,156 +2	+0.2%	+$109	0.01%	490
2024 Q2	$58.7K	Buy	+1,154	New	+$57.1K	0.01%	454
2023 Q4	$52.7K	Hold	1,152	–	–	0.01%	486
2023 Q3	$54.4K	Hold	1,152	–	–	0.02%	284
2023 Q2	$50.1K	Buy	+1,152	New	+$50.7K	0.01%	367
2023 Q1	–	Sell	-1,152	Closed	-$54.4K	–	890
2022 Q4	$54.4K	Buy	+1,152	New	+$52.2K	0.02%	287

Other funds holding RXL

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Coppell Advisory Solutions's RXL Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of ProShares Ultra Health Care (RXL) in Q1 2025, closing a stake of 1,156 shares — an estimated $50.8K sold.

Coppell Advisory Solutions first reported a position in RXL in Q4 2022 and held it in 7 quarters. The position peaked at $63.9K in Q3 2024. 16 funds tracked by Wall St. Rank hold RXL as of Q1 2025.

Coppell Advisory Solutions reported no remaining ProShares Ultra Health Care position as of Q1 2025 after selling out during the quarter.
Coppell Advisory Solutions sold 1,156 ProShares Ultra Health Care shares in Q1 2025, an estimated $50.8K.
Coppell Advisory Solutions first reported a position in ProShares Ultra Health Care in Q4 2022 and held it in 7 quarters.
Coppell Advisory Solutions's ProShares Ultra Health Care position peaked at $63.9K in Q3 2024.
16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.